Sickle Cell Disease and the Fight Against Intersectional Bias in Healthcare
A poignant storyline in the first season of the show “The Pitt” – depicting a Black woman with sickle cell disease initially dismissed as drug-seeking in an emergency department – has sparked renewed attention to systemic biases within healthcare. This isn’t merely a fictional portrayal; experts confirm it reflects a harsh reality for many individuals living with sickle cell disease.
Unpacking the Layers of Bias
Recent research from the University of Chicago Medicine, published in JAMA Network Open, delves into the complex interplay of factors contributing to disparities in care. The study identifies that negative descriptors in clinician notes for sickle cell patients are closely linked to stigma surrounding opioid use, potentially overshadowing the impact of race or chronic pain alone.
Monica Peek, MD, MPH, of UChicago Medicine, explains the challenge of pinpointing the source of discrimination. “Part of the issue for Black patients – and many marginalized groups – is that many in this population have multiple social identities that may be stigmatized… So when patients experience discrimination in healthcare, it is challenging to pinpoint what identity may be triggering the behavior.”
The Data Behind the Disparities
The UChicago Medicine study analyzed electronic health records of over 18,000 adults, examining nearly 40,000 clinician notes for negative descriptors like “aggressive,” “noncooperative,” and “noncompliant.” Findings revealed that patients with sickle cell disease had higher odds of these negative descriptors compared to Black patients and those with chronic pain. However, their odds were similar to patients with opioid use disorder, suggesting a strong connection between bias and opioid stigma.
This builds on previous research showing Black patients are more than 2.5 times more likely to have negative descriptors in their medical records compared to white patients. Further studies have demonstrated that biased language in patient records can lead to decreased clinician empathy and inaccurate recall of critical health details.
Beyond Stigma: The Reality of Pain Management
A key issue highlighted by researchers is the misconception surrounding opioid use in sickle cell disease. While patients often require opioid medications to manage chronic pain, the vast majority do not have an opioid use disorder. “Whereas patients with sickle cell disease routinely use opioid medications to manage their chronic pain, the vast majority do not have an opioid use disorder,” notes Peek. “It is a testament to the strength of their character that they do their best to live full lives while managing debilitating pain.”
Austin Wesevich, MD, emphasizes the importance of trust in the patient-clinician relationship. “Clinicians cannot measure pain directly without asking the patient, so it’s a choice to believe patients when they share their pain levels… a patient with sickle cell disease who experiences daily pain and who happens to be Black and asking for opioid treatment deserves no less trust than any other patient.”
Innovative Solutions: Anti-Bias Curriculum
Recognizing the need for change, UChicago Medicine has developed an anti-bias curriculum designed to mitigate these issues. The program utilizes skills-based learning through roleplay, coupled with education on how biases negatively impact care quality. Early data suggests the intervention is effective, with other institutions already expressing interest in adopting the curriculum.
Pro Tip: Healthcare organizations can proactively address bias by implementing similar training programs, promoting diversity within their staff, and fostering a culture of empathy and respect.
Future Trends in Addressing Healthcare Disparities
The focus on intersectional bias in sickle cell care signals a broader trend toward recognizing the complex factors influencing health outcomes. Expect to see increased use of natural language processing (NLP) and machine learning to identify and address bias in electronic health records. The development of standardized pain assessment tools and culturally sensitive communication strategies will be crucial.
The success of the UChicago Medicine intervention highlights the potential of targeted educational programs. Future initiatives may incorporate virtual reality simulations to provide clinicians with immersive experiences that challenge their biases and promote empathy.
FAQ
Q: What is sickle cell disease?
A: A genetic blood disorder that causes red blood cells to become sickle-shaped, leading to pain and other complications.
Q: Why are patients with sickle cell disease often stigmatized?
A: Stigma often stems from misconceptions about pain management and opioid use, as well as racial biases.
Q: What can be done to address bias in healthcare?
A: Implementing anti-bias training, promoting diversity, and fostering a culture of empathy are key steps.
Q: What role does technology play in identifying bias?
A: NLP and machine learning can analyze electronic health records to identify patterns of biased language.
Did you know? Patients with sickle cell disease often experience chronic pain that significantly impacts their quality of life. Effective pain management is essential, but often hindered by bias and stigma.
Learn more about sickle cell disease and ongoing research at the University of Chicago Medical Center.
What are your thoughts on this issue? Share your experiences and insights in the comments below!
